首页 > 最新文献

Contemporary clinical trials最新文献

英文 中文
Study design and methodologies for the men moving forward lifestyle intervention trial with black prostate cancer survivors 黑人前列腺癌幸存者男性生活方式干预试验的研究设计和方法。
IF 1.9 3区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-24 DOI: 10.1016/j.cct.2025.108205
Iwalola Awoyinka , Patricia Sheean , Paula Papanek , Kathryn E. Flynn , Kathryn Bylow , Deepak Kilari , Peter Gann , Anjishnu Banerjee , Melinda Stolley

Backgound

Prostate cancer (PC) incidence and mortality rates are significantly higher among Black/African-American (Black) men compared to men of other race/ethnicities. Comorbidities and compromised quality of life are also greater challenges for this community of men. Many factors drive these differences among which body composition and health behaviors are important, yet modifiable contributors. Lifestyle interventions report beneficial results for PC survivors; however, the inclusion of Black men is critically limited. This paper describes Men Moving Forward (MMF) –a community-based lifestyle intervention for Black men with PC.

Methods/Design

This trial will randomize (1:1) 200 Black men with PC who completed treatment or are on active surveillance. The 16-week MMF intervention, conducted in partnership with the Milwaukee Recreation system, supports adoption of the American Cancer Society Nutrition and Physical Activity guidelines. Measures of body composition (primary), behavior (diet, physical activity), fitness, quality of life, and biomarkers of general health and PC recurrence risk are collected at baseline, post-intervention and at a 12-month follow-up. The primary hypothesis is that men receiving the MMF intervention will exhibit greater changes in body composition than those in the wait-list control group.

Discussion

The MMF trial addresses an important gap in the current literature, evaluating the potential efficacy of a lifestyle program developed with and for Black men with PC. Outcomes including body composition and biomarkers of general health and PC recurrence risk add to our knowledge and methodologies on health behaviors and PC survivorship. Study results will inform survivorship efforts for this high-risk, underrepresented population.
U.S. Clinicaltrials.gov number: NCT03971591, 06.01.2019.
背景:与其他种族/族裔的男性相比,黑人/非裔美国人(黑人)男性的前列腺癌(PC)发病率和死亡率明显更高。合并症和生活质量下降也是这一群体面临的更大挑战。许多因素导致了这些差异,其中身体组成和健康行为是重要的,但可以改变的因素。生活方式干预报告对PC幸存者有益;然而,黑人男性的参与非常有限。本文描述了男性前进(MMF) -一个以社区为基础的生活方式干预黑人男性PC。方法/设计:本试验将随机抽取(1:1)200名已完成治疗或正在积极监测的黑人男性PC患者。与密尔沃基娱乐系统合作进行的为期16周的MMF干预,支持采用美国癌症协会营养和体育活动指南。在基线、干预后和12个月随访时收集身体组成(主要)、行为(饮食、身体活动)、健康、生活质量和一般健康和PC复发风险的生物标志物。主要的假设是,接受MMF干预的男性在身体成分上的变化比那些等候名单对照组的男性更大。讨论:MMF试验解决了当前文献中的一个重要空白,评估了为患有PC的黑人男性开发的生活方式计划的潜在功效。结果包括身体组成和一般健康的生物标志物以及前列腺癌复发风险,增加了我们对健康行为和前列腺癌生存率的认识和方法。研究结果将为这一高风险、未被充分代表的人群的生存努力提供信息。美国临床试验:gov编号:NCT03971591, 06.01.2019。
{"title":"Study design and methodologies for the men moving forward lifestyle intervention trial with black prostate cancer survivors","authors":"Iwalola Awoyinka ,&nbsp;Patricia Sheean ,&nbsp;Paula Papanek ,&nbsp;Kathryn E. Flynn ,&nbsp;Kathryn Bylow ,&nbsp;Deepak Kilari ,&nbsp;Peter Gann ,&nbsp;Anjishnu Banerjee ,&nbsp;Melinda Stolley","doi":"10.1016/j.cct.2025.108205","DOIUrl":"10.1016/j.cct.2025.108205","url":null,"abstract":"<div><h3>Backgound</h3><div>Prostate cancer (PC) incidence and mortality rates are significantly higher among Black/African-American (Black) men compared to men of other race/ethnicities. Comorbidities and compromised quality of life are also greater challenges for this community of men. Many factors drive these differences among which body composition and health behaviors are important, yet modifiable contributors. Lifestyle interventions report beneficial results for PC survivors; however, the inclusion of Black men is critically limited. This paper describes Men Moving Forward (MMF) –a community-based lifestyle intervention for Black men with PC.</div></div><div><h3>Methods/Design</h3><div>This trial will randomize (1:1) 200 Black men with PC who completed treatment or are on active surveillance. The 16-week MMF intervention, conducted in partnership with the Milwaukee Recreation system, supports adoption of the American Cancer Society Nutrition and Physical Activity guidelines. Measures of body composition (primary), behavior (diet, physical activity), fitness, quality of life, and biomarkers of general health and PC recurrence risk are collected at baseline, post-intervention and at a 12-month follow-up. The primary hypothesis is that men receiving the MMF intervention will exhibit greater changes in body composition than those in the wait-list control group.</div></div><div><h3>Discussion</h3><div>The MMF trial addresses an important gap in the current literature, evaluating the potential efficacy of a lifestyle program developed with and for Black men with PC. Outcomes including body composition and biomarkers of general health and PC recurrence risk add to our knowledge and methodologies on health behaviors and PC survivorship. Study results will inform survivorship efforts for this high-risk, underrepresented population.</div><div>U.S. <span><span>Clinicaltrials.gov</span><svg><path></path></svg></span> number: <span><span>NCT03971591</span><svg><path></path></svg></span>, 06.01.2019.</div></div>","PeriodicalId":10636,"journal":{"name":"Contemporary clinical trials","volume":"161 ","pages":"Article 108205"},"PeriodicalIF":1.9,"publicationDate":"2025-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145843578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kinesiologist-delivered mobilization to mitigate inpatient frailty: A study protocol for a randomized controlled trial 运动学家提供的活动减轻住院病人虚弱:一项随机对照试验的研究方案。
IF 1.9 3区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-24 DOI: 10.1016/j.cct.2025.108204
Madeline E. Shivgulam , Mathieu Dumont , Shirko Ahmadi , Molly Courish , Luc Barrieau , Luc Cormier , Olga Theou , Saïd Mekari , Myles W. O'Brien

Background

Hospitalized older adults spend excessive amounts of time in sedentary postures (sitting/lying while awake). Mobilizing patients may prevent physical deconditioning, exacerbated frailty levels, and worsened hospital outcomes. The purpose of this study will be to test the hypothesis that compared to usual care, patients who receive multiple kinesiologist visits each day will, 1) increase their step counts and upright time, 2) decrease their frailty levels from admission to discharge, and 3) have shorter lengths of stays and decreased readmission rates.

Methods

Sixty middle-aged-to-older adult patients (≥50 years) from a general/internal medicine unit will be randomized into a usual care control (visit from the kinesiologist once/day) or intervention group (multiple visits from the kinesiologist/day). Kinesiologist visits will include individualized patient mobilization. All participants will be equipped with three waterproofed activPAL inclinometers positioned on their thigh, torso, and shin for 24-h/day throughout hospitalization to measure physical activity (step counts, physical activity intensity), upright postures, and detailed sedentary postures (bent-legged sitting, straight-legged sitting, lying). Frailty will be assessed via a validated 65-item index and the Clinical Frailty Scale two weeks before admission (retrospectively), at admission, and at discharge. Secondary measures will include length of stay and hospital re-admissions. Mixed models for repeated measures will determine whether daily activity differed between groups, changed throughout hospital stay, and effected frailty levels.

Discussion

This randomized controlled trial will aim to refine mobilization strategies and individualize interventions for the prevention of decline in mobility and worsening frailty among hospitalized patients.
Trial Registration: The protocol has been registered at clinicaltrials.gov (identifier: NCT06802289).
背景:住院的老年人在久坐姿势(醒着时坐着/躺着)上花费的时间过多。动员患者可能会防止身体机能丧失,加剧虚弱程度,并恶化医院结果。本研究的目的是验证以下假设:与常规护理相比,每天接受多次运动学专家访问的患者将:1)增加他们的步数和直立时间,2)减少他们从入院到出院的虚弱程度,3)住院时间更短,再入院率降低。方法:60名来自普通/内科的中老年成人患者(≥50 岁)将被随机分为常规护理对照组(运动技师每天一次访问)或干预组(运动技师每天多次访问)。运动学专家的访问将包括患者的个体化活动。所有参与者将在住院期间每天24小时在大腿、躯干和胫骨上安装三个防水的activPAL倾斜仪,以测量身体活动(步数、身体活动强度)、直立姿势和详细的久坐姿势(曲腿坐、直腿坐、躺)。虚弱将在入院前两周(回顾性)、入院时和出院时通过一个经过验证的65项指数和临床虚弱量表进行评估。次要措施包括住院时间和再次入院。重复测量的混合模型将确定各组之间的日常活动是否不同,在整个住院期间是否发生变化,以及是否影响虚弱程度。讨论:本随机对照试验旨在完善活动策略和个性化干预措施,以预防住院患者活动能力下降和虚弱恶化。试验注册:该方案已在clinicaltrials.gov注册(标识符:NCT06802289)。
{"title":"Kinesiologist-delivered mobilization to mitigate inpatient frailty: A study protocol for a randomized controlled trial","authors":"Madeline E. Shivgulam ,&nbsp;Mathieu Dumont ,&nbsp;Shirko Ahmadi ,&nbsp;Molly Courish ,&nbsp;Luc Barrieau ,&nbsp;Luc Cormier ,&nbsp;Olga Theou ,&nbsp;Saïd Mekari ,&nbsp;Myles W. O'Brien","doi":"10.1016/j.cct.2025.108204","DOIUrl":"10.1016/j.cct.2025.108204","url":null,"abstract":"<div><h3>Background</h3><div>Hospitalized older adults spend excessive amounts of time in sedentary postures (sitting/lying while awake). Mobilizing patients may prevent physical deconditioning, exacerbated frailty levels, and worsened hospital outcomes. The purpose of this study will be to test the hypothesis that compared to usual care, patients who receive multiple kinesiologist visits each day will, 1) increase their step counts and upright time, 2) decrease their frailty levels from admission to discharge, and 3) have shorter lengths of stays and decreased readmission rates.</div></div><div><h3>Methods</h3><div>Sixty middle-aged-to-older adult patients (≥50 years) from a general/internal medicine unit will be randomized into a usual care control (visit from the kinesiologist once/day) or intervention group (multiple visits from the kinesiologist/day). Kinesiologist visits will include individualized patient mobilization. All participants will be equipped with three waterproofed activPAL inclinometers positioned on their thigh, torso, and shin for 24-h/day throughout hospitalization to measure physical activity (step counts, physical activity intensity), upright postures, and detailed sedentary postures (bent-legged sitting, straight-legged sitting, lying). Frailty will be assessed via a validated 65-item index and the Clinical Frailty Scale two weeks before admission (retrospectively), at admission, and at discharge. Secondary measures will include length of stay and hospital re-admissions. Mixed models for repeated measures will determine whether daily activity differed between groups, changed throughout hospital stay, and effected frailty levels.</div></div><div><h3>Discussion</h3><div>This randomized controlled trial will aim to refine mobilization strategies and individualize interventions for the prevention of decline in mobility and worsening frailty among hospitalized patients.</div><div>Trial Registration: The protocol has been registered at <span><span>clinicaltrials.gov</span><svg><path></path></svg></span> (identifier: <span><span>NCT06802289</span><svg><path></path></svg></span>).</div></div>","PeriodicalId":10636,"journal":{"name":"Contemporary clinical trials","volume":"161 ","pages":"Article 108204"},"PeriodicalIF":1.9,"publicationDate":"2025-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145843541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pediatric asthma management via integration of a remote spirometry device into an EHR-based artificial intelligence-powered clinical decision support system: A feasibility pragmatic clinical trial 通过将远程肺活量测量设备集成到基于ehr的人工智能临床决策支持系统中的儿科哮喘管理:一项可行性实用临床试验
IF 1.9 3区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-24 DOI: 10.1016/j.cct.2025.108209
Lynnea Myers , Tracey A. Brereton , Shauna Overgaard , Jason D. Greenwood , Lu Zheng , Joshua W. Ohde , Matthew Spiten , R.N. Kathy Ihrke , Kristi Lang , Kevin Peterson , Stephen Hawley , Madison Beenken , M. Malik , Josh Bublitz , Taylor Galloway , Quantia Wilkes , Danielle Shrader , Lydia Mercado , Miguel Park , Manuel Arteta , Young Juhn

Background

Asthma is the most common chronic disease in children. Suboptimal asthma control is prevalent and causes significant health care costs. Electronic health records (EHRs) contain vast data which pose a major challenge for timely and efficient access to relevant information for clinical decision making. To address this challenge, a machine learning and natural language processing models-powered clinical decision support system (CDS) called Asthma-Guidance Prediction System (A-GPS) was developed. A-GPS automatically extracts and synthesizes pertinent patient data from EHRs for asthma management. To further enhance A-GPS, real-time patient data was added from a home spirometry device and mobile app system (AsthmaTuner), that remotely collected patient-reported outcomes for asthma control and lung function and delivered a clinician-prescribed Asthma Action Plan from EHR to patients. The goal of the study was to assess the feasibility and satisfaction of implementation of an integrated A-GPS with AsthmaTuner for remote asthma management within pediatric primary care.

Methods

Study design was a parallel-group, non-blinded, dual-site, 2-arm pragmatic, randomized clinical trial (RCT) with 22 dyads (one clinician and one pediatric patient) at Mayo Clinic Health System and Mayo Clinic, Rochester, Minnesota. The primary endpoint was successful implementation of the integrated A-GPS with AsthmaTuner in primary care and study participants' satisfaction.

Conclusion

The technological integration and application of the integrated A-GPS and AsthmaTuner in primary care as a clinical CDS for remote asthma management was feasible. This protocol provides developers with a framework for the best practices for evaluating AI tools and enables digital technology via an RCT.
Trial Registration: Registered via ClinicalTrials.gov NCT06062433

Significance

We anticipate this study will establish a conceptual and operational framework for implementing AI-powered CDS in pediatric asthma management, with the goal that these methodological advancements will be expanded to the management of adults with asthma and other chronic complex diseases. Reporting a clinical trial protocol for the evaluation of an AI tool and following the reporting guidelines are valuable for establishing best practices evaluating AI tools, specifically for the developers and other key stakeholders who plan to evaluate AI models via RCTs in health care settings. We plan to communicate our trial results via publication and reporting in ClinicalTrials.gov database (NCT06062433). Authorship on publications will follow international standards for authorship (i.e., ICMJE).
背景:哮喘是儿童最常见的慢性疾病。亚理想的哮喘控制是普遍存在的,并造成巨大的卫生保健费用。电子健康记录(EHRs)包含大量数据,这对及时有效地获取临床决策所需的相关信息构成了重大挑战。为了应对这一挑战,开发了一种机器学习和自然语言处理模型驱动的临床决策支持系统(CDS),称为哮喘引导预测系统(a- gps)。A-GPS自动提取和综合相关的患者数据从电子病历哮喘管理。为了进一步增强a - gps,添加了来自家庭肺活量测量设备和移动应用系统(AsthmaTuner)的实时患者数据,远程收集患者报告的哮喘控制和肺功能结果,并将临床医生处方的哮喘行动计划从EHR传递给患者。本研究的目的是评估在儿科初级保健中实施A-GPS与AsthmaTuner集成的远程哮喘管理的可行性和满意度。方法:研究设计为一项平行组、非盲、双中心、两组、随机临床试验(RCT), 22对夫妇(一名临床医生和一名儿科患者)在明尼苏达州罗切斯特市梅奥诊所和梅奥诊所进行。主要终点是A-GPS与AsthmaTuner在初级保健中的成功实施和研究参与者的满意度。结论:综合a - gps与asthma matuner在基层医疗中的技术整合与应用,作为哮喘远程管理的临床CDS是可行的。该协议为开发人员提供了评估人工智能工具的最佳实践框架,并通过RCT实现了数字技术。意义:我们预计本研究将为在儿童哮喘管理中实施人工智能驱动的CDS建立一个概念和操作框架,目标是将这些方法学上的进步扩展到成人哮喘和其他慢性复杂疾病的管理。报告用于评估人工智能工具的临床试验方案并遵循报告准则,对于建立评估人工智能工具的最佳做法非常有价值,特别是对于计划在卫生保健环境中通过随机对照试验评估人工智能模型的开发人员和其他关键利益攸关方。我们计划通过ClinicalTrials.gov数据库(NCT06062433)的发布和报告来传达我们的试验结果。出版物的作者身份将遵循国际作者标准(即ICMJE)。
{"title":"Pediatric asthma management via integration of a remote spirometry device into an EHR-based artificial intelligence-powered clinical decision support system: A feasibility pragmatic clinical trial","authors":"Lynnea Myers ,&nbsp;Tracey A. Brereton ,&nbsp;Shauna Overgaard ,&nbsp;Jason D. Greenwood ,&nbsp;Lu Zheng ,&nbsp;Joshua W. Ohde ,&nbsp;Matthew Spiten ,&nbsp;R.N. Kathy Ihrke ,&nbsp;Kristi Lang ,&nbsp;Kevin Peterson ,&nbsp;Stephen Hawley ,&nbsp;Madison Beenken ,&nbsp;M. Malik ,&nbsp;Josh Bublitz ,&nbsp;Taylor Galloway ,&nbsp;Quantia Wilkes ,&nbsp;Danielle Shrader ,&nbsp;Lydia Mercado ,&nbsp;Miguel Park ,&nbsp;Manuel Arteta ,&nbsp;Young Juhn","doi":"10.1016/j.cct.2025.108209","DOIUrl":"10.1016/j.cct.2025.108209","url":null,"abstract":"<div><h3>Background</h3><div>Asthma is the most common chronic disease in children. Suboptimal asthma control is prevalent and causes significant health care costs. Electronic health records (EHRs) contain vast data which pose a major challenge for timely and efficient access to relevant information for clinical decision making. To address this challenge, a machine learning and natural language processing models-powered clinical decision support system (CDS) called Asthma-Guidance Prediction System (A-GPS) was developed. A-GPS automatically extracts and synthesizes pertinent patient data from EHRs for asthma management. To further enhance A-GPS, real-time patient data was added from a home spirometry device and mobile app system (AsthmaTuner), that remotely collected patient-reported outcomes for asthma control and lung function and delivered a clinician-prescribed Asthma Action Plan from EHR to patients. The goal of the study was to assess the feasibility and satisfaction of implementation of an integrated A-GPS with AsthmaTuner for remote asthma management within pediatric primary care.</div></div><div><h3>Methods</h3><div>Study design was a parallel-group, non-blinded, dual-site, 2-arm pragmatic, randomized clinical trial (RCT) with 22 dyads (one clinician and one pediatric patient) at Mayo Clinic Health System and Mayo Clinic, Rochester, Minnesota. The primary endpoint was successful implementation of the integrated A-GPS with AsthmaTuner in primary care and study participants' satisfaction.</div></div><div><h3>Conclusion</h3><div>The technological integration and application of the integrated A-GPS and AsthmaTuner in primary care as a clinical CDS for remote asthma management was feasible. This protocol provides developers with a framework for the best practices for evaluating AI tools and enables digital technology via an RCT.</div><div>Trial Registration: Registered via <span><span>ClinicalTrials.gov</span><svg><path></path></svg></span> <span><span>NCT06062433</span><svg><path></path></svg></span></div></div><div><h3>Significance</h3><div>We anticipate this study will establish a conceptual and operational framework for implementing AI-powered CDS in pediatric asthma management, with the goal that these methodological advancements will be expanded to the management of adults with asthma and other chronic complex diseases. Reporting a clinical trial protocol for the evaluation of an AI tool and following the reporting guidelines are valuable for establishing best practices evaluating AI tools, specifically for the developers and other key stakeholders who plan to evaluate AI models via RCTs in health care settings. We plan to communicate our trial results via publication and reporting in <span><span>ClinicalTrials.gov</span><svg><path></path></svg></span> database (<span><span>NCT06062433</span><svg><path></path></svg></span>). Authorship on publications will follow international standards for authorship (i.e., ICMJE).</div></div>","PeriodicalId":10636,"journal":{"name":"Contemporary clinical trials","volume":"161 ","pages":"Article 108209"},"PeriodicalIF":1.9,"publicationDate":"2025-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145843562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
STARRS-PC: A stepped approach to reducing suicide in primary care: Design and methods of a hybrid type 1 effectiveness-implementation trial STARRS-PC:减少初级保健自杀的分步方法:混合型1效实施试验的设计和方法
IF 1.9 3区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-24 DOI: 10.1016/j.cct.2025.108208
Cynthia A. Fontanella , Jennifer L. Hughes , Guy Brock , Donna A. Ruch , Alex R. Kemper , Alicia C. Bunger , Dan M. Walker , Ann Scheck McAlearney , Tensing Maa , Melissa Miller , Priyanka Desirazu , Jeremy Obee , Jeffrey A. Bridge

Background

Suicide is the second leading cause of death among youth aged 12–17. Although most at-risk youth receive primary care, routine screening is limited in primary care due to provider discomfort, time constraints, limited training, and inadequate referral sources. Research evaluating and implementing suicide prevention strategies in pediatric primary care is vitally needed.

Purpose

We aim to test the effectiveness of the Stepped Approach to Reducing Suicide in Primary Care (STARRS-PC), a population-based quality improvement intervention implementing a structured clinical pathway consisting of risk detection, assessment and triage, and follow-up with transitional care.

Methods

A stepped wedge cluster randomized design will evaluate the effectiveness of STARRS-PC compared to treatment as usual (TAU) across 16 primary care sites. 2324 adolescents aged 12–17 screening positive for suicide risk will be enrolled (1033 in the TAU phase; 1291 in the intervention phase). Primary outcomes include suicide attempts and deaths. Secondary outcomes are suicidal ideation, non-suicidal self-injury, and family satisfaction. Youth and parents will complete assessments at baseline, 3, 6, and 12 months. Tests of moderation and mediation will be conducted to understand finding generalizability and identify variables that change as a result of the intervention and are associated with suicide attempts/death. Implementation outcomes (reach, adoption, maintenance, feasibility, and acceptability) will be evaluated through provider surveys and qualitative interviews.

Conclusions

This study will provide evidence on the effectiveness and implementation of a quality improvement supported, structured suicide prevention pathway in pediatric primary care, which could transform youth suicide risk identification and management.
背景自杀是12-17岁青少年死亡的第二大原因。虽然大多数高危青年接受初级保健,但由于提供者不适、时间限制、培训有限和转诊来源不足,初级保健的常规筛查受到限制。研究评估和实施自杀预防策略在儿科初级保健是至关重要的。目的:我们的目的是测试减少初级保健自杀的阶梯式方法(STARRS-PC)的有效性,这是一种基于人群的质量改善干预措施,实施结构化的临床途径,包括风险检测、评估和分诊,以及过渡性护理的随访。方法采用阶梯楔形聚类随机设计,在16个初级保健站点评估STARRS-PC与常规治疗(TAU)的有效性。2324名12-17岁自杀风险筛查阳性的青少年将被纳入研究(1033名在TAU阶段,1291名在干预阶段)。主要结果包括自杀企图和死亡。次要结果是自杀意念、非自杀性自残和家庭满意度。青少年和家长将在基线、3、6和12个月时完成评估。将进行适度和调解测试,以了解发现普遍性,并确定由于干预而发生变化并与自杀企图/死亡有关的变量。实现结果(覆盖范围、采用、维护、可行性和可接受性)将通过提供者调查和定性访谈进行评估。结论本研究将为儿科初级保健中质量改进支持的结构化自杀预防路径的有效性和实施提供证据,该路径可以改变青少年自杀风险的识别和管理。
{"title":"STARRS-PC: A stepped approach to reducing suicide in primary care: Design and methods of a hybrid type 1 effectiveness-implementation trial","authors":"Cynthia A. Fontanella ,&nbsp;Jennifer L. Hughes ,&nbsp;Guy Brock ,&nbsp;Donna A. Ruch ,&nbsp;Alex R. Kemper ,&nbsp;Alicia C. Bunger ,&nbsp;Dan M. Walker ,&nbsp;Ann Scheck McAlearney ,&nbsp;Tensing Maa ,&nbsp;Melissa Miller ,&nbsp;Priyanka Desirazu ,&nbsp;Jeremy Obee ,&nbsp;Jeffrey A. Bridge","doi":"10.1016/j.cct.2025.108208","DOIUrl":"10.1016/j.cct.2025.108208","url":null,"abstract":"<div><h3>Background</h3><div>Suicide is the second leading cause of death among youth aged 12–17. Although most at-risk youth receive primary care, routine screening is limited in primary care due to provider discomfort, time constraints, limited training, and inadequate referral sources. Research evaluating and implementing suicide prevention strategies in pediatric primary care is vitally needed.</div></div><div><h3>Purpose</h3><div>We aim to test the effectiveness of the Stepped Approach to Reducing Suicide in Primary Care (STARRS-PC), a population-based quality improvement intervention implementing a structured clinical pathway consisting of risk detection, assessment and triage, and follow-up with transitional care.</div></div><div><h3>Methods</h3><div>A stepped wedge cluster randomized design will evaluate the effectiveness of STARRS-PC compared to treatment as usual (TAU) across 16 primary care sites. 2324 adolescents aged 12–17 screening positive for suicide risk will be enrolled (1033 in the TAU phase; 1291 in the intervention phase). Primary outcomes include suicide attempts and deaths. Secondary outcomes are suicidal ideation, non-suicidal self-injury, and family satisfaction. Youth and parents will complete assessments at baseline, 3, 6, and 12 months. Tests of moderation and mediation will be conducted to understand finding generalizability and identify variables that change as a result of the intervention and are associated with suicide attempts/death. Implementation outcomes (reach, adoption, maintenance, feasibility, and acceptability) will be evaluated through provider surveys and qualitative interviews.</div></div><div><h3>Conclusions</h3><div>This study will provide evidence on the effectiveness and implementation of a quality improvement supported, structured suicide prevention pathway in pediatric primary care, which could transform youth suicide risk identification and management.</div></div>","PeriodicalId":10636,"journal":{"name":"Contemporary clinical trials","volume":"161 ","pages":"Article 108208"},"PeriodicalIF":1.9,"publicationDate":"2025-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145838280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
iMprovIng the meNtal hEalth of home healTh AiDeS: A study protocol for the MINDSET study 改善家庭护理员的心理健康:心态研究的研究方案。
IF 1.9 3区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-21 DOI: 10.1016/j.cct.2025.108200
Madeline R. Sterling , Michelle Shum , Ronica Peramsetty , Joselyne Aucapina , Faith Wiggins , Carmen Colon , Joanna Bryan Ringel , Ariel C. Avgar , Nicola Dell , Bibi N. Habib , Samprit Banerjee , Emma Tsui , Susan J. Andreae , Elissa Kozlov , Courtney Landis , Ian René Solano-Kamaiko , Monika M. Safford
Home health aides and attendants (HHAs) are a fast-growing healthcare workforce who are integral to the rising movement that allows older adults to age in place. However, HHAs themselves are a vulnerable group of caregivers. Mostly middle-aged women of color paid dismally low wages, HHAs' work is physically taxing, emotionally challenging, and socially isolating. Consequently, HHAs have high levels of depressive symptoms and stress. Prior studies suggest that HHAs want to address this, but do not know how and cannot access or afford traditional mental health services. Here we describe the protocol for a pilot randomized control trial (RCT) that aims to improve the mental health of HHAs through peer coaching (PC), an established and effective behavioral health intervention which has never been applied to HHAs or their workplace, the home environment. In collaboration with a labor and management fund of the largest healthcare union in the US (1199SEIU), we will conduct a single-site parallel arm pilot RCT with 100 HHAs to evaluate the feasibility, acceptability, and effectiveness of an adapted Living Healthy Program for HHAs delivered by PCs (intervention arm) vs. a general health promotion program (attention control arm). Primary effectiveness outcome will be a reduction in depressive symptoms; secondary effectiveness outcomes will be a reduction in stress and loneliness. This study offers a novel and potentially scalable way to improve the health of HHAs, an often overlooked, undervalued, but increasingly vital workforce that is needed to care for our rapidly aging population.
家庭健康助理和护理人员(HHAs)是一个快速增长的医疗保健劳动力,他们是日益增长的老年人养老运动中不可或缺的一部分。然而,卫生保健机构本身是一个脆弱的照顾者群体。他们大多是有色人种的中年女性,工资低得令人沮丧,他们的工作是体力劳动,情感挑战,社会孤立。因此,hha患者有高水平的抑郁症状和压力。先前的研究表明,卫生保健机构想要解决这个问题,但不知道如何解决,也无法获得或负担得起传统的精神卫生服务。在此,我们描述了一项随机对照试验(RCT)的方案,旨在通过同伴指导(PC)改善hha的心理健康,这是一种从未应用于hha或其工作场所,家庭环境的既定有效的行为健康干预。与美国最大的医疗保健工会(1199SEIU)的劳动和管理基金合作,我们将对100名hha进行单点平行对照试验,以评估由pc(干预组)和一般健康促进计划(注意控制组)为hha提供的适应性健康生活计划的可行性、可接受性和有效性。主要有效结果将是抑郁症状的减轻;第二有效的结果将是减少压力和孤独感。这项研究提供了一种新颖的、潜在的可扩展的方法来改善hha的健康状况,hha是一个经常被忽视、被低估,但越来越重要的劳动力,需要照顾我们迅速老龄化的人口。
{"title":"iMprovIng the meNtal hEalth of home healTh AiDeS: A study protocol for the MINDSET study","authors":"Madeline R. Sterling ,&nbsp;Michelle Shum ,&nbsp;Ronica Peramsetty ,&nbsp;Joselyne Aucapina ,&nbsp;Faith Wiggins ,&nbsp;Carmen Colon ,&nbsp;Joanna Bryan Ringel ,&nbsp;Ariel C. Avgar ,&nbsp;Nicola Dell ,&nbsp;Bibi N. Habib ,&nbsp;Samprit Banerjee ,&nbsp;Emma Tsui ,&nbsp;Susan J. Andreae ,&nbsp;Elissa Kozlov ,&nbsp;Courtney Landis ,&nbsp;Ian René Solano-Kamaiko ,&nbsp;Monika M. Safford","doi":"10.1016/j.cct.2025.108200","DOIUrl":"10.1016/j.cct.2025.108200","url":null,"abstract":"<div><div>Home health aides and attendants (HHAs) are a fast-growing healthcare workforce who are integral to the rising movement that allows older adults to age in place. However, HHAs themselves are a vulnerable group of caregivers. Mostly middle-aged women of color paid dismally low wages, HHAs' work is physically taxing, emotionally challenging, and socially isolating. Consequently, HHAs have high levels of depressive symptoms and stress. Prior studies suggest that HHAs want to address this, but do not know how and cannot access or afford traditional mental health services. Here we describe the protocol for a pilot randomized control trial (RCT) that aims to improve the mental health of HHAs through peer coaching (PC), an established and effective behavioral health intervention which has never been applied to HHAs or their workplace, the home environment. In collaboration with a labor and management fund of the largest healthcare union in the US (1199SEIU), we will conduct a single-site parallel arm pilot RCT with 100 HHAs to evaluate the feasibility, acceptability, and effectiveness of an adapted <em>Living Healthy Program for HHAs</em> delivered by PCs (intervention arm) vs. a general health promotion program (attention control arm). Primary effectiveness outcome will be a reduction in depressive symptoms; secondary effectiveness outcomes will be a reduction in stress and loneliness. This study offers a novel and potentially scalable way to improve the health of HHAs, an often overlooked, undervalued, but increasingly vital workforce that is needed to care for our rapidly aging population.</div></div>","PeriodicalId":10636,"journal":{"name":"Contemporary clinical trials","volume":"161 ","pages":"Article 108200"},"PeriodicalIF":1.9,"publicationDate":"2025-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145818368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The pharmaceutically enhanced reinforcement for reduced alcohol and smoking (PERRAS) study: Protocol for a randomized clinical trial 减少酒精和吸烟的药物增强强化(PERRAS)研究:一项随机临床试验方案。
IF 1.9 3区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-19 DOI: 10.1016/j.cct.2025.108189
Paola Palombo , Nicole Akana , Abigail Bowen , Alex Schmidt , Rachel Ryan , Sean Hovland , B. Connor Stark , Nicole Rodin , Naomi Chaytor , Michael G. McDonell , Ekaterina Burduli , Matthew Layton , John M. Roll , Crystal L. Smith , André Q. Miguel , Sterling M. McPherson

Background

Alcohol and tobacco are often used together, and their co-use is directly associated with a high incidence of morbidity and mortality. While there are currently no guidelines for treating co-addiction to alcohol and tobacco, studies suggest that integrated approaches may effectively reduce the use of both substances. Grounded in the Addiction Neuroclinical Assessment (ANA) framework, this study aims to evaluate the effectiveness of combining Contingency Management (CM) for Alcohol Use Disorder (AUD) with Varenicline for smoking cessation to significantly reduce alcohol and tobacco use among individuals with an AUD who smoke and are seeking treatment. In addition, the study will evaluate the mediator effect of the ANA domains, systematically measured and evaluated to determine their role in treatment outcomes.

Methods

Study will take place in Spokane-WA. After a two-week induction period, a total of 205 eligible participants will be randomized into one of two 12-week treatment conditions in equal proportions: CM + varenicline (experimental condition) and Non-Contingent (NC) + varenicline (control condition). Participants in the CM + varenicline group will receive rewards contingent on the submission of negative alcohol samples, while the NC + varenicline group will receive rewards for submitting urine samples, independent of alcohol positivity. Primary outcomes include objective verification of abstinence during the 12-week intervention phase (measured thrice-weekly). Follow-up evaluations will be conducted during the first, third, and sixth months.

Conclusions

If demonstrated to be efficacious, this treatment approach has the potential to produce important health benefits for a highly prevalent population in desperate need for an integrated treatment. It may also assist in identifying how different ANA-based responses impact treatment outcomes.
背景:酒精和烟草经常一起使用,它们的共同使用与高发病率和高死亡率直接相关。虽然目前没有治疗酒精和烟草双重成瘾的指导方针,但研究表明,综合方法可以有效地减少这两种物质的使用。在成瘾神经临床评估(ANA)框架的基础上,本研究旨在评估将酒精使用障碍(AUD)的应急管理(CM)与伐尼克兰戒烟相结合的有效性,以显着减少吸烟并正在寻求治疗的AUD患者的酒精和烟草使用。此外,该研究将评估ANA结构域的中介作用,系统地测量和评估以确定其在治疗结果中的作用。方法:研究将在华盛顿州斯波坎市进行。在两周的诱导期后,共有205名符合条件的参与者将被随机分配到两种为期12周的治疗条件之一:CM + 伐尼克兰(实验条件)和非偶然(NC) + 伐尼克兰(对照条件)。CM + varenicline组的参与者将根据提交的阴性酒精样本获得奖励,而NC + varenicline组的参与者将根据提交的尿液样本获得奖励,与酒精阳性无关。主要结果包括在12周的干预阶段(每周测量三次)对戒断的客观验证。后续评估将在第一个月、第三个月和第六个月进行。结论:如果证明有效,这种治疗方法有可能为迫切需要综合治疗的高度流行人群带来重要的健康益处。它还可以帮助确定不同的基于ana的反应如何影响治疗结果。
{"title":"The pharmaceutically enhanced reinforcement for reduced alcohol and smoking (PERRAS) study: Protocol for a randomized clinical trial","authors":"Paola Palombo ,&nbsp;Nicole Akana ,&nbsp;Abigail Bowen ,&nbsp;Alex Schmidt ,&nbsp;Rachel Ryan ,&nbsp;Sean Hovland ,&nbsp;B. Connor Stark ,&nbsp;Nicole Rodin ,&nbsp;Naomi Chaytor ,&nbsp;Michael G. McDonell ,&nbsp;Ekaterina Burduli ,&nbsp;Matthew Layton ,&nbsp;John M. Roll ,&nbsp;Crystal L. Smith ,&nbsp;André Q. Miguel ,&nbsp;Sterling M. McPherson","doi":"10.1016/j.cct.2025.108189","DOIUrl":"10.1016/j.cct.2025.108189","url":null,"abstract":"<div><h3>Background</h3><div>Alcohol and tobacco are often used together, and their co-use is directly associated with a high incidence of morbidity and mortality. While there are currently no guidelines for treating co-addiction to alcohol and tobacco, studies suggest that integrated approaches may effectively reduce the use of both substances. Grounded in the Addiction Neuroclinical Assessment (ANA) framework, this study aims to evaluate the effectiveness of combining Contingency Management (CM) for Alcohol Use Disorder (AUD) with Varenicline for smoking cessation to significantly reduce alcohol and tobacco use among individuals with an AUD who smoke and are seeking treatment. In addition, the study will evaluate the mediator effect of the ANA domains, systematically measured and evaluated to determine their role in treatment outcomes.</div></div><div><h3>Methods</h3><div>Study will take place in Spokane-WA. After a two-week induction period, a total of 205 eligible participants will be randomized into one of two 12-week treatment conditions in equal proportions: CM + varenicline (experimental condition) and Non-Contingent (NC) + varenicline (control condition). Participants in the CM + varenicline group will receive rewards contingent on the submission of negative alcohol samples, while the NC + varenicline group will receive rewards for submitting urine samples, independent of alcohol positivity. Primary outcomes include objective verification of abstinence during the 12-week intervention phase (measured thrice-weekly). Follow-up evaluations will be conducted during the first, third, and sixth months.</div></div><div><h3>Conclusions</h3><div>If demonstrated to be efficacious, this treatment approach has the potential to produce important health benefits for a highly prevalent population in desperate need for an integrated treatment. It may also assist in identifying how different ANA-based responses impact treatment outcomes.</div></div>","PeriodicalId":10636,"journal":{"name":"Contemporary clinical trials","volume":"161 ","pages":"Article 108189"},"PeriodicalIF":1.9,"publicationDate":"2025-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145803361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Virtual Intervention for Binge Eating (VIBE): Study protocol for a user-informed mobile intervention for dysregulated eating and weight gain prevention in adolescents 暴饮暴食的虚拟干预(VIBE):针对青少年饮食失调和体重增加预防的用户知情移动干预研究方案
IF 1.9 3区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-18 DOI: 10.1016/j.cct.2025.108192
Andrea B. Goldschmidt , Adrian Ortega , Isabel R. Rooper , Katrina T. Obleada , Danielle A.N. Chapa , Basia Silverberg , Erin Stalvey , Macarena Kruger Camino , Michele D. Levine , Lan Yu , Dawn M. Eichen , Andrea K. Graham

Background

Pediatric overweight and obesity continue to be major public health issues. Loss of control (LOC) eating and overeating are two obesity-related phenotypes affecting approximately 30 % of adolescents with overweight/obesity that may undermine weight control treatment outcome. Cognitive-behavioral therapy (CBT) has promising effects on dysregulated eating, but effects on weight are modest, access is limited, and developmental changes in self-regulation (which may limit implementation of treatment skills) are often ignored. Methods: In the current proposal, we will apply human-centered design methods to design and test a novel CBT-based digital intervention, augmented with content and features to improve self-regulation, for weight gain prevention and dysregulated eating in adolescents. The first phase will involve design activities with adolescents (n = 25–30) who have body mass index (BMI; kg/m2) ≥ 75th percentile for age and sex and report dysregulated eating, to understand desired presentation, features, and barriers/facilitators to engagement. Research activities will include a needs assessment and iterative prototyping, usability testing, and refinement of the digital intervention. The second phase will be a multisite single arm open trial involving 50 adolescents who have or are at risk for overweight/obesity and report LOC and/or overeating to investigate intervention feasibility and preliminary efficacy, as well as putative treatment mechanisms and targets. Conclusions: Results of the study will inform the design of an adequately powered randomized controlled trial. The project has clear potential to significantly impact public health via development of a relevant, accessible, and scalable intervention for adolescents at risk for adverse physical and mental health outcomes.
Clinical trial registration number: NCT06819813
儿童超重和肥胖仍然是主要的公共卫生问题。饮食失控(LOC)和暴饮暴食是两种与肥胖相关的表型,影响了大约30%的超重/肥胖青少年,这可能会破坏体重控制治疗结果。认知行为疗法(CBT)对饮食失调有很好的效果,但对体重的影响不大,获取途径有限,而且自我调节的发育变化(这可能限制治疗技巧的实施)经常被忽视。方法:在当前的提案中,我们将应用以人为本的设计方法来设计和测试一种新的基于cbt的数字干预,增强内容和功能,以提高自我调节,预防青少年体重增加和饮食失调。第一阶段将涉及青少年(n = 25-30)的设计活动,他们的身体质量指数(BMI; kg/m2)≥年龄和性别的第75个百分位数,并报告饮食失调,以了解期望的表现、特征和参与的障碍/促进因素。研究活动将包括需求评估和迭代原型、可用性测试以及数字干预的细化。第二阶段将是一项多地点单臂开放试验,涉及50名患有或有超重/肥胖风险并报告LOC和/或暴饮暴食的青少年,以调查干预的可行性和初步疗效,以及假定的治疗机制和目标。结论:研究结果将为设计一项足够有力的随机对照试验提供信息。该项目显然有可能通过为面临不利身心健康结果风险的青少年制定相关、可获得和可扩展的干预措施,对公共卫生产生重大影响。临床试验注册号:NCT06819813
{"title":"Virtual Intervention for Binge Eating (VIBE): Study protocol for a user-informed mobile intervention for dysregulated eating and weight gain prevention in adolescents","authors":"Andrea B. Goldschmidt ,&nbsp;Adrian Ortega ,&nbsp;Isabel R. Rooper ,&nbsp;Katrina T. Obleada ,&nbsp;Danielle A.N. Chapa ,&nbsp;Basia Silverberg ,&nbsp;Erin Stalvey ,&nbsp;Macarena Kruger Camino ,&nbsp;Michele D. Levine ,&nbsp;Lan Yu ,&nbsp;Dawn M. Eichen ,&nbsp;Andrea K. Graham","doi":"10.1016/j.cct.2025.108192","DOIUrl":"10.1016/j.cct.2025.108192","url":null,"abstract":"<div><h3>Background</h3><div>Pediatric overweight and obesity continue to be major public health issues. Loss of control (LOC) eating and overeating are two obesity-related phenotypes affecting approximately 30 % of adolescents with overweight/obesity that may undermine weight control treatment outcome. Cognitive-behavioral therapy (CBT) has promising effects on dysregulated eating, but effects on weight are modest, access is limited, and developmental changes in self-regulation (which may limit implementation of treatment skills) are often ignored. <u>Methods</u>: In the current proposal, we will apply human-centered design methods to design and test a novel CBT-based digital intervention, augmented with content and features to improve self-regulation, for weight gain prevention and dysregulated eating in adolescents. The first phase will involve design activities with adolescents (<em>n</em> = 25–30) who have body mass index (BMI; kg/m<sup>2</sup>) ≥ 75th percentile for age and sex and report dysregulated eating, to understand desired presentation, features, and barriers/facilitators to engagement. Research activities will include a needs assessment and iterative prototyping, usability testing, and refinement of the digital intervention. The second phase will be a multisite single arm open trial involving 50 adolescents who have or are at risk for overweight/obesity and report LOC and/or overeating to investigate intervention feasibility and preliminary efficacy, as well as putative treatment mechanisms and targets. <u>Conclusions</u>: Results of the study will inform the design of an adequately powered randomized controlled trial. The project has clear potential to significantly impact public health via development of a relevant, accessible, and scalable intervention for adolescents at risk for adverse physical and mental health outcomes.</div><div><strong>Clinical trial registration number</strong>: <span><span>NCT06819813</span><svg><path></path></svg></span></div></div>","PeriodicalId":10636,"journal":{"name":"Contemporary clinical trials","volume":"161 ","pages":"Article 108192"},"PeriodicalIF":1.9,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145789069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Geographic location and clinical trial knowledge, invitation, and participation among adults in the United States 美国成年人的地理位置和临床试验知识、邀请和参与。
IF 1.9 3区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-18 DOI: 10.1016/j.cct.2025.108193
Henry K. Onyeaka , Manfred N. Mate-Kole , Irene A. Acheampong , Abigail Arthur , M. Tim Song , Ted O. Akhiwu , Diana Mensah , Chioma Ozoalor , Onyema G. Chido-Amajuoyi , Hermioni L. Amonoo

Background/Aims

Clinical trials are essential to evaluating novel treatments and improving disease-related outcomes through innovative therapies. Despite underrepresentation of rural communities in clinical trial outreach and participation, geographic disparities in clinical trials have been minimally explored. We examined clinical trial knowledge, invitation, and participation among participants in urban and rural geographic locations in the United States.

Methods

We conducted cross-sectional data analysis on self-reported data from Health Information National Trends Survey (HINTS) 5 Cycle 4. Population-level estimates were obtained using jack-knife replicate weights.

Results

Geographic location was not associated with clinical trial knowledge, invitation, and participation. However, the relatively low absolute invitation rates across urban and rural populations may suggest that substantial gaps in recruitment persist universally, regardless of geographic location in the United States.

Conclusions

In this nationally representative study, we found no statistically significant differences in clinical trial knowledge, invitation or participation by geographical location in the United States. Our findings suggest that geographic residence may not be a primary barrier to clinical trial engagement once sociodemographic differences are accounted for. Targeted efforts to improve awareness and reduce structural barriers, along with continued investment in equitable recruitment strategies, will be important to ensuring that clinical trials reflect the diversity of the populations they aim to serve.
背景/目的:临床试验对于评估新疗法和通过创新疗法改善疾病相关结局至关重要。尽管农村社区在临床试验推广和参与方面的代表性不足,但对临床试验的地理差异进行了最低限度的探索。我们检查了美国城乡参与者的临床试验知识、邀请和参与情况。方法:对健康信息全国趋势调查(HINTS) 5 Cycle 4的自报数据进行横断面数据分析。使用千斤顶重复权重获得种群水平估计值。结果:地理位置与临床试验知识、邀请和参与无关。然而,城市和农村人口相对较低的绝对邀请率可能表明,无论美国的地理位置如何,招聘方面的巨大差距都普遍存在。结论:在这项具有全国代表性的研究中,我们发现美国临床试验知识、邀请或参与的地理位置没有统计学上的显著差异。我们的研究结果表明,一旦考虑到社会人口统计学差异,地理居住地可能不是临床试验参与的主要障碍。提高认识和减少结构性障碍的有针对性的努力,以及对公平招聘战略的持续投资,对于确保临床试验反映其目标服务人群的多样性至关重要。
{"title":"Geographic location and clinical trial knowledge, invitation, and participation among adults in the United States","authors":"Henry K. Onyeaka ,&nbsp;Manfred N. Mate-Kole ,&nbsp;Irene A. Acheampong ,&nbsp;Abigail Arthur ,&nbsp;M. Tim Song ,&nbsp;Ted O. Akhiwu ,&nbsp;Diana Mensah ,&nbsp;Chioma Ozoalor ,&nbsp;Onyema G. Chido-Amajuoyi ,&nbsp;Hermioni L. Amonoo","doi":"10.1016/j.cct.2025.108193","DOIUrl":"10.1016/j.cct.2025.108193","url":null,"abstract":"<div><h3>Background/Aims</h3><div>Clinical trials are essential to evaluating novel treatments and improving disease-related outcomes through innovative therapies. Despite underrepresentation of rural communities in clinical trial outreach and participation, geographic disparities in clinical trials have been minimally explored. We examined clinical trial knowledge, invitation, and participation among participants in urban and rural geographic locations in the United States.</div></div><div><h3>Methods</h3><div>We conducted cross-sectional data analysis on self-reported data from Health Information National Trends Survey (HINTS) 5 Cycle 4. Population-level estimates were obtained using jack-knife replicate weights.</div></div><div><h3>Results</h3><div>Geographic location was not associated with clinical trial knowledge, invitation, and participation. However, the relatively low absolute invitation rates across urban and rural populations may suggest that substantial gaps in recruitment persist universally, regardless of geographic location in the United States.</div></div><div><h3>Conclusions</h3><div>In this nationally representative study, we found no statistically significant differences in clinical trial knowledge, invitation or participation by geographical location in the United States. Our findings suggest that geographic residence may not be a primary barrier to clinical trial engagement once sociodemographic differences are accounted for. Targeted efforts to improve awareness and reduce structural barriers, along with continued investment in equitable recruitment strategies, will be important to ensuring that clinical trials reflect the diversity of the populations they aim to serve.</div></div>","PeriodicalId":10636,"journal":{"name":"Contemporary clinical trials","volume":"161 ","pages":"Article 108193"},"PeriodicalIF":1.9,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145800107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Remotely-delivered exercise training program among older adults with multiple sclerosis: Feasibility results of a randomized controlled trial 老年多发性硬化症患者远程运动训练项目:一项随机对照试验的可行性结果
IF 1.9 3区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-17 DOI: 10.1016/j.cct.2025.108190
Peixuan Zheng , Sydney R. DeJonge , Noah G. DuBose , Ariel Kidwell-Chandler , Trevor B. Martin , Trinh L.T. Huynh , Shane A. Phillips , Jennifer Duffecy , Robert W. Motl

Background

Older adults with multiple sclerosis (MS) are often physically inactive and present with walking and cognitive impairments that may be remediated through rehabilitation approaches such as exercise training.

Objectives

We conducted a phase-Ib, randomized controlled trial (RCT) that examined the feasibility and initial efficacy of a 16-week remotely-delivered, home-based exercise training program in older adults with MS who had moderate mobility disability.

Methods

This study utilized a parallel-group RCT design. Participants (n = 51; mean age = 60.5 years, 78 % females) were randomized into exercise training (aerobic and resistance) or active control (stretching) conditions. Both conditions were undertaken within a participant's home/community and remotely supported by a behavioral coach. Participants received training manuals and equipment, one-on-one behavioral coaching, action-planning calendars, self-monitoring logs, and social cognitive theory-based newsletters. Feasibility was assessed across process, resource, management, and scientific domains. Scientific outcomes focused on physical function, cognition, and physical activity, with data collected by treatment-blinded assessors.

Results

The intervention was cost-effective, accessible, well-received, and safe based on formative evaluation. Forty-one (80.4 %) participants completed the conditions, with adherence and compliance rates across conditions exceeding 80 %. There were moderate-to-large improvements in walking speed, functional mobility, lower-extremity function, and verbal learning and memory (p < 0.05, |d| = 0.58–0.80) in the exercise condition, but not in control (p > 0.05).

Conclusions

This study established the feasibility and initial efficacy of a theory-based, remotely-delivered exercise training intervention for older adults with MS. The promising results support the design and implementation of a subsequent, phase-II RCT for improving physical and cognitive functions in the older MS population.
背景:患有多发性硬化症(MS)的老年人通常缺乏运动,并且存在行走和认知障碍,这些障碍可以通过运动训练等康复方法来修复。目的:我们进行了一项ib期随机对照试验(RCT),研究了一项为期16周的远程递送、基于家庭的运动训练计划在患有中度行动障碍的老年MS患者中的可行性和初步疗效。方法采用平行组随机对照试验设计。参与者(n = 51,平均年龄= 60.5岁,78%为女性)被随机分为运动训练(有氧和阻力)和主动控制(拉伸)两组。这两种情况都是在参与者家中/社区进行的,并由行为教练远程支持。参与者收到了培训手册和设备、一对一的行为指导、行动计划日历、自我监控日志和基于社会认知理论的新闻通讯。可行性是跨过程、资源、管理和科学领域进行评估的。科学结果集中于身体功能、认知和身体活动,数据由治疗盲法评估者收集。结果在形成性评价的基础上,该干预具有成本效益、可及性、良好的接受度和安全性。41名(80.4%)参与者完成了条件,各条件的依从性和依从率超过80%。运动组在步行速度、功能活动能力、下肢功能和语言学习记忆方面均有中重度改善(p < 0.05, |d| = 0.58-0.80),对照组无显著改善(p > 0.05)。本研究建立了一种基于理论的远程运动训练干预对老年MS患者的可行性和初步疗效,这一令人鼓舞的结果支持了后续ii期随机对照试验的设计和实施,以改善老年MS人群的身体和认知功能。
{"title":"Remotely-delivered exercise training program among older adults with multiple sclerosis: Feasibility results of a randomized controlled trial","authors":"Peixuan Zheng ,&nbsp;Sydney R. DeJonge ,&nbsp;Noah G. DuBose ,&nbsp;Ariel Kidwell-Chandler ,&nbsp;Trevor B. Martin ,&nbsp;Trinh L.T. Huynh ,&nbsp;Shane A. Phillips ,&nbsp;Jennifer Duffecy ,&nbsp;Robert W. Motl","doi":"10.1016/j.cct.2025.108190","DOIUrl":"10.1016/j.cct.2025.108190","url":null,"abstract":"<div><h3>Background</h3><div>Older adults with multiple sclerosis (MS) are often physically inactive and present with walking and cognitive impairments that may be remediated through rehabilitation approaches such as exercise training.</div></div><div><h3>Objectives</h3><div>We conducted a phase-Ib, randomized controlled trial (RCT) that examined the feasibility and initial efficacy of a 16-week remotely-delivered, home-based exercise training program in older adults with MS who had moderate mobility disability.</div></div><div><h3>Methods</h3><div>This study utilized a parallel-group RCT design. Participants (<em>n</em> = 51; mean age = 60.5 years, 78 % females) were randomized into exercise training (aerobic and resistance) or active control (stretching) conditions. Both conditions were undertaken within a participant's home/community and remotely supported by a behavioral coach. Participants received training manuals and equipment, one-on-one behavioral coaching, action-planning calendars, self-monitoring logs, and social cognitive theory-based newsletters. Feasibility was assessed across process, resource, management, and scientific domains. Scientific outcomes focused on physical function, cognition, and physical activity, with data collected by treatment-blinded assessors.</div></div><div><h3>Results</h3><div>The intervention was cost-effective, accessible, well-received, and safe based on formative evaluation. Forty-one (80.4 %) participants completed the conditions, with adherence and compliance rates across conditions exceeding 80 %. There were moderate-to-large improvements in walking speed, functional mobility, lower-extremity function, and verbal learning and memory (<em>p</em> &lt; 0.05, <em>|d|</em> = 0.58–0.80) in the exercise condition, but not in control (<em>p</em> &gt; 0.05).</div></div><div><h3>Conclusions</h3><div>This study established the feasibility and initial efficacy of a theory-based, remotely-delivered exercise training intervention for older adults with MS. The promising results support the design and implementation of a subsequent, phase-II RCT for improving physical and cognitive functions in the older MS population.</div></div>","PeriodicalId":10636,"journal":{"name":"Contemporary clinical trials","volume":"161 ","pages":"Article 108190"},"PeriodicalIF":1.9,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145789180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Basic needs navigation intervention to address multidimensional adversity in African Americans with diabetic kidney disease: A pilot randomized clinical trial protocol 基本需求导航干预解决非裔美国糖尿病肾病患者的多维逆境:一项试点随机临床试验方案
IF 1.9 3区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-17 DOI: 10.1016/j.cct.2025.108183
Mukoso N. Ozieh , Charity G. Patterson , Joni S. Williams , Rebekah J. Walker , Leonard E. Egede

Background

Diabetic kidney disease (DKD) is the leading cause of end stage kidney disease (ESKD) in the United States. African Americans have a risk of developing chronic kidney disease and are almost four times more likely to progress to ESKD compared to non-Hispanic whites. The presence of social adversities impacts the complex self-management of DKD and negatively impacts health outcomes. Patient navigation interventions offer a promising strategy to improve health outcomes in individuals with chronic disease. However, it is not known whether a basic needs navigation intervention that addresses social adversities in combination with patient education and lifestyle coaching leads to improved clinical and patient-centered outcomes.

Methods and analysis

This ongoing 3-year two-arm pilot randomized clinical trial will test the feasibility of a basic needs navigation intervention in African American adults with DKD experiencing multidimensional adversity (having one or more social adversity). Fifty African American adults with DKD experiencing one or more social adversity and who have uncontrolled diabetes (HbA1c 8 % or more) will be randomized into one of two arms: 1) basic needs navigation intervention arm or 2) enhanced usual care arm. The primary clinical outcome is feasibility of the basic needs navigation intervention as measured by recruitment, session attendance and retention.

Discussion

The results of this study will serve as a first step in addressing current gaps in knowledge and will provide feasibility data for a large-scale appropriately powered, randomized clinical trial focused on addressing social adversity in African American adults with DKD.

Ethics and dissemination

This trial was approved by Medical College of Wisconsin IRB Protocol # PRO00041675.

Trial registration number

Registration for this trial can be found under ID: NCT05357742 and online (https://clinicaltrials.gov/ct2/show/NCT05357742?id=NCT05357742&draw=2&rank=1) on the NIH U.S. National Library of Medicine Clinical Trials Database.
背景:糖尿病肾病(DKD)是美国终末期肾病(ESKD)的主要原因。非裔美国人有患慢性肾脏疾病的风险,与非西班牙裔白人相比,他们发展为ESKD的可能性几乎是后者的四倍。社会逆境的存在影响了DKD复杂的自我管理,并对健康结果产生负面影响。患者导航干预提供了一个有希望的策略,以改善个人健康结果与慢性疾病。然而,目前尚不清楚的是,解决社会逆境的基本需求导航干预与患者教育和生活方式指导相结合是否会改善临床和以患者为中心的结果。方法和分析:这项正在进行的为期3年的两组随机临床试验将测试基本需求导航干预在经历多维逆境(有一个或多个社会逆境)的非洲裔美国成人DKD患者中的可行性。50名患有DKD的非裔美国成年人经历一个或多个社会逆境,并患有未控制的糖尿病(HbA1c为8.0 %或更高),将被随机分为两组:1)基本需求导航干预组或2)强化常规护理组。主要临床结果是基本需求导航干预的可行性,通过招募,会议出席率和保留来衡量。讨论:本研究的结果将作为解决当前知识空白的第一步,并将为大规模适当的随机临床试验提供可行性数据,该试验的重点是解决非洲裔美国成人DKD患者的社会逆境。伦理与传播:该试验已获得威斯康星医学院IRB协议# PRO00041675的批准。试验注册号:该试验的注册可以在ID: NCT05357742和NIH美国国家医学临床试验数据库在线(https://clinicaltrials.gov/ct2/show/NCT05357742?id=NCT05357742&draw=2&rank=1)上找到。
{"title":"Basic needs navigation intervention to address multidimensional adversity in African Americans with diabetic kidney disease: A pilot randomized clinical trial protocol","authors":"Mukoso N. Ozieh ,&nbsp;Charity G. Patterson ,&nbsp;Joni S. Williams ,&nbsp;Rebekah J. Walker ,&nbsp;Leonard E. Egede","doi":"10.1016/j.cct.2025.108183","DOIUrl":"10.1016/j.cct.2025.108183","url":null,"abstract":"<div><h3>Background</h3><div>Diabetic kidney disease (DKD) is the leading cause of end stage kidney disease (ESKD) in the United States. African Americans have a risk of developing chronic kidney disease and are almost four times more likely to progress to ESKD compared to non-Hispanic whites. The presence of social adversities impacts the complex self-management of DKD and negatively impacts health outcomes. Patient navigation interventions offer a promising strategy to improve health outcomes in individuals with chronic disease. However, it is not known whether a basic needs navigation intervention that addresses social adversities in combination with patient education and lifestyle coaching leads to improved clinical and patient-centered outcomes.</div></div><div><h3>Methods and analysis</h3><div>This ongoing 3-year two-arm pilot randomized clinical trial will test the feasibility of a basic needs navigation intervention in African American adults with DKD experiencing multidimensional adversity (having one or more social adversity). Fifty African American adults with DKD experiencing one or more social adversity and who have uncontrolled diabetes (HbA1c 8 % or more) will be randomized into one of two arms: 1) basic needs navigation intervention arm or 2) enhanced usual care arm. The primary clinical outcome is feasibility of the basic needs navigation intervention as measured by recruitment, session attendance and retention.</div></div><div><h3>Discussion</h3><div>The results of this study will serve as a first step in addressing current gaps in knowledge and will provide feasibility data for a large-scale appropriately powered, randomized clinical trial focused on addressing social adversity in African American adults with DKD.</div></div><div><h3>Ethics and dissemination</h3><div>This trial was approved by Medical College of Wisconsin IRB Protocol # PRO00041675.</div></div><div><h3>Trial registration number</h3><div>Registration for this trial can be found under ID: <span><span>NCT05357742</span><svg><path></path></svg></span> and online (<span><span>https://clinicaltrials.gov/ct2/show/NCT05357742?id=NCT05357742&amp;draw=2&amp;rank=1</span><svg><path></path></svg></span>) on the NIH U.S. National Library of Medicine Clinical Trials Database.</div></div>","PeriodicalId":10636,"journal":{"name":"Contemporary clinical trials","volume":"161 ","pages":"Article 108183"},"PeriodicalIF":1.9,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145793408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Contemporary clinical trials
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1